The UK government has made an additional £175 million ($212 million) in funding available for its push to make the country a go-to location for clinical research, adding to £200 million pro
GSK's recently-unveiled plan to develop a bioscience cluster close to its main R&D site in Stevenage, UK, has moved closer to fruition, now that the first partners have joined the initi
Moderna has said it will open a new R&D and manufacturing facility in the UK which could lead to improved access by NHS patients to mRNA-based vaccines and drug treatments.
Canary Wharf's bid to become a new hub for the life sciences sector in the UK has been given a boost following the decision by Genomics England to relocate to the development.